SGH
Sivik Global Healthcare Portfolio holdings
AUM
$127M
1-Year Est. Return
20.09%
This Fund
S&P 500
1 Year Est. Return
+20.09%
AUM
$127M
AUM Growth
-$78.2M
(-38%)
Holding
55
Top Buys
| 1 | +$5.13M | |
| 2 | +$4.66M | |
| 3 | +$3.06M | |
| 4 |
Elevance Health
ELV
|
+$1.64M |
| 5 |
CVS Health
CVS
|
+$1.54M |
Top Sells
| 1 | +$9.36M | |
| 2 | +$7M | |
| 3 | +$4.46M | |
| 4 |
Medtronic
MDT
|
+$4.32M |
| 5 |
Repligen
RGEN
|
+$4.1M |
Sector Composition
| 1 | Healthcare | 84.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P Biotech ETF
XBI
$8.86B
| $19.2M | 15.13% |
150,000
-75,000
|
|
||
2
Cardinal Health
CAH
$50.4B
| $5.07M | 4% |
24,000
-8,500
|
|
||
3
Johnson & Johnson
JNJ
$556B
| $4.89M | 3.86% |
+20,000
|
|
||
4
Merck
MRK
$289B
| $4.81M | 3.8% |
40,000
+10,000
|
|
||
5
Cencora
COR
$63.7B
| $4.71M | 3.72% |
15,000
-3,000
|
|
||
6
Eli Lilly
LLY
$822B
| $4.6M | 3.63% |
5,000
-2,000
|
|
||
7
Waters Corp
WAT
$32.9B
| $4.47M | 3.53% |
+15,000
|
|
||
8
Vertex Pharmaceuticals
VRTX
$112B
| $4.46M | 3.53% |
10,000
-3,770
|
|
||
9
Intuitive Surgical
ISRG
$165B
| $4.15M | 3.28% |
9,000
-1,000
|
|
||
10
AstraZeneca
AZN
$311B
| $3.94M | 3.11% |
20,000
-20,000
|
|
||
11
Thermo Fisher Scientific
TMO
$195B
| $3.93M | 3.1% |
8,000
-4,000
|
|
||
12
Boston Scientific
BSX
$90.6B
| $3.89M | 3.07% |
62,000
-8,000
|
|
||
13
Danaher
DHR
$138B
| $3.79M | 2.99% |
20,000
-3,000
|
|
||
14
Tenet Healthcare
THC
$16.8B
| $3.77M | 2.98% |
20,000
-17,500
|
|
||
15
Gilead Sciences
GILD
$169B
| $3.48M | 2.75% |
25,000
|
|
||
16
Humana
HUM
$25.3B
| $3.47M | 2.74% |
20,000
+5,000
|
|
||
17
Mettler-Toledo International
MTD
$26.8B
| $3.47M | 2.74% |
2,750
-250
|
|
||
18
McKesson
MCK
$105B
| $3.46M | 2.73% |
4,000
-5,000
|
|
||
19
Agilent Technologies
A
$34.2B
| $3.42M | 2.7% |
30,000
-5,000
|
|
||
20
Stryker
SYK
$131B
| $3.29M | 2.59% |
10,000
-3,000
|
|
||
21
AbbVie
ABBV
$360B
| $3.26M | 2.58% |
15,000
-5,000
|
|
||
22
Universal Health Services
UHS
$11.1B
| $3.13M | 2.47% |
17,500
-10,500
|
|
||
23
Regeneron Pharmaceuticals
REGN
$79.2B
| $3.09M | 2.44% |
+4,000
|
|
||
24
Bio-Rad Laboratories Class A
BIO
$8.07B
| $2.79M | 2.2% |
10,000
-2,000
|
|
||
25
Biogen
BIIB
$26.9B
| $2.75M | 2.17% |
15,000
-5,000
|
|